In acute lymphoblastic leukemia cells (Jurkat, MOLT-3, and CEM), CBD (30 μM) promoted a possible interaction with the VDAC1 receptor, mitochondrial alteration with pore formation, cytochrome C release, and cell death by apoptosis and autophagy. Here, CYCS is linked to acute lymphoblastic leukemia.